EUVIMEDEUVIMED entdecken
Editorial

Is an inhaled biologic a better approach to treat asthma?

William W Busse, Ravi Viswanathan

Journal of Allergy and Clinical Immunology · 2026-08 · 158 (2) · 392-394

DOI: 10.1016/j.jaci.2026.05.025 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-08. Verfasst von William W Busse und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic add…. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Inhaled biologicsTSLPairway inflammationasthmabiologics in severe asthma

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: wwb@medicine.wisc.edu.
  • Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.

Zitieren

APA

Busse, W. W., & Viswanathan, R. (2026). Is an inhaled biologic a better approach to treat asthma?. Journal of Allergy and Clinical Immunology, 158(2), 392-394. https://doi.org/10.1016/j.jaci.2026.05.025

Vancouver

Busse WW, Viswanathan R. Is an inhaled biologic a better approach to treat asthma?. Journal of Allergy and Clinical Immunology. 2026;158(2):392-394. doi:10.1016/j.jaci.2026.05.025

BibTeX
@article{Busse2026,
  author = {Busse, William W and Viswanathan, Ravi},
  title = {Is an inhaled biologic a better approach to treat asthma?},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {2},
  pages = {392--394},
  doi = {10.1016/j.jaci.2026.05.025}
}
Kostenlos starten →